Disease: Nipah virus encephalitis
- <em>N</em><sup>4</sup> -Hydroxycytidine/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced Fitness
- <em>Pteropus vampyrus</em> TRIM40 Is an Interferon-Stimulated Gene That Antagonizes RIG-I-like Receptors
- A Novel DNAzyme-Based Fluorescent Biosensor for Detection of RNA-Containing Nipah Henipavirus
- A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses
- A Revised Diagnostic Quantitative RT-PCR for the Detection of Nipah Virus Infection
- A Survey of Henipavirus Tropism-Our Current Understanding from a Species/Organ and Cellular Level
- A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease
- Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics
- Advancing the frontiers: Revolutionary control and prevention paradigms against Nipah virus
- An integrated multi-pronged reverse vaccinology and biophysical approaches for identification of potential vaccine candidates against Nipah virus
- An mRNA-based reverse-vaccinology strategy to stimulate the immune response against Nipah virus in humans using fusion glycoproteins
- An Overview of Conventional and Black Cumin Seeds (<em>Nigella sativa</em>) Therapy in the Management of Nipah Viral Infection
- An Overview of Conventional and Black Cumin Seeds (Nigella sativa) Therapy in the Management of Nipah Viral Infection
- Animal Models for Henipavirus Research
- Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach
- Biological Weapon Toxicity
- Central nervous system infections in the tropics
- Clinico-epidemiological presentations and management of Nipah virus infection during the outbreak in Kozhikode district, Kerala state, India 2023
- Common and Potential Emerging Foodborne Viruses: A Comprehensive Review
- Confusion in Langya Henipavirus and Severity of Infection: A Preliminary Observation
- Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8
- Development and laboratory evaluation of a competitive ELISA for serodiagnosis of Nipah and Hendra virus infection using recombinant Nipah glycoproteins and a monoclonal antibody
- Development of Preventive Measures and Treatment Strategies Against Nipah Virus is a Timely Need: Bangladeshi Perspective
- Establishment of a Nipah Virus Disease Model in Hamsters, including a Comparison of Intranasal and Intraperitoneal Routes of Challenge
- Etiology of Meningoencephalitis in children aged less than 5 years
- Evaluation of the interaction between potent small molecules against the Nipah virus Glycoprotein in Malaysia and Bangladesh strains, accompanied by the human Ephrin-B2 and Ephrin-B3 receptors; a simulation approach
- Experimental infection of tick cells with Nipah virus
- Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health
- Ferret Models for Henipavirus Infection
- Generation of a Porcine Cell Line Stably Expressing Pig TMPRSS2 for Efficient Isolation of Swine Influenza Virus
- Genomic characterization, transcriptome analysis, and pathogenicity of the Nipah virus (Indian isolate)
- Hendra Virus: An Update on Diagnosis, Vaccination, and Biosecurity Protocols for Horses
- Henipavirus Matrix Protein Employs a Non-Classical Nuclear Localization Signal Binding Mechanism
- Henipavirus naming and regional discrimination
- Henipavirus zoonosis: outbreaks, animal hosts and potential new emergence
- Henipavirus-induced neuropathogenesis in mice
- Host Transcriptome Analysis of Ferret Tissues Following Henipavirus Infection
- Host-Pathogen Interactions Influencing Zoonotic Spillover Potential and Transmission in Humans
- Human Exposure to Bats, Rodents and Monkeys in Bangladesh
- Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
- Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease
- In silico prediction of interaction between Nipah virus attachment glycoprotein and host cell receptors Ephrin-B2 and Ephrin-B3 in domestic and peridomestic mammals
- In silico screening of herbal phytochemicals to develop a Rasayana for immunity against Nipah virus
- In Vivo Imaging of Nipah Virus Infection in Small Animal Rodent Models
- Inactivated Recombinant Rabies Virus Displaying the Nipah Virus Envelope Glycoproteins Induces Systemic Immune Responses in Mice
- Infectious Causes of Acute Encephalitis Syndrome in India - Decadal Change and the Way Forward
- Infectious Causes of Acute Encephalitis Syndrome in India: Decadal Change and the Way Forward
- Isolation of Primary Porcine Bronchial Epithelial Cells for Nipah Virus Infections
- Langya henipavirus outbreak
- Late remdesivir treatment initiation partially protects African green monkeys from lethal Nipah virus infection
- Molecular Determinants of Fibrillation in a Viral Amyloidogenic Domain from Combined Biochemical and Biophysical Studies
- Molecular Pathogenesis of Nipah Virus
- Mouse Models of Henipavirus Infection
- N(4) -Hydroxycytidine/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced Fitness
- Nipah virus attachment glycoprotein ectodomain delivered by type 5 adenovirus vector elicits broad immune response against NiV and HeV
- Nipah Virus Bangladesh Infection Elicits Organ-Specific Innate and Inflammatory Responses in the Marmoset Model
- Nipah Virus Disease: Epidemiological, Clinical, Diagnostic and Legislative Aspects of This Unpredictable Emerging Zoonosis
- NIPAH Virus Encephalitis: Unveiling the Epidemiology, Risk Factors, and Clinical Outcomes - A Systematic Review and Meta-Analysis
- Nipah Virus Exposure in Domestic and Peridomestic Animals Living in Human Outbreak Sites, Bangladesh, 2013-2015
- Nipah Virus Infection and False Negative: Concern in Laboratory Surveillance
- Nipah virus is deadly - but smart policy changes can help quell pandemic risk
- Nipah Virus: A Multidimensional Update
- Nipah virus: a re-emerging public health concern
- Nipah virus: an ever-present threat
- Nipah Virus: An Overview of the Current Status of Diagnostics and Their Role in Preparedness in Endemic Countries
- Nipah: The looming post-covid pandemic
- Novel "GaEl Antigenic Patches" Identified by a "Reverse Epitomics" Approach to Design Multipatch Vaccines against NIPAH Infection, a Silent Threat to Global Human Health
- Outcome and Sequelae of Infectious Encephalitis
- Overview of Experimental Vaccines and Antiviral Therapeutics for Henipavirus Infection
- Paramyxoviruses in rodents: A review
- Pathogenicity and virulence of henipaviruses
- Possible high risk of transmission of the Nipah virus in South and South East Asia: a review
- Potent human neutralizing antibodies against Nipah virus derived from two ancestral antibody heavy chains
- Potential for Person-to-Person Transmission of Henipaviruses: A Systematic Review of the Literature
- Predicting the next pandemic: VACCELERATE ranking of the World health Organization's Blueprint for action to prevent epidemics
- Predicting the next pandemic: VACCELERATE ranking of the WorldHealth Organization's Blueprint forAction toPreventEpidemics
- Prefusion stabilization of the Hendra and Langya virus F proteins
- Primary Culture of the Human Olfactory Neuroepithelium and Utilization for Henipavirus Infection In Vitro
- Profiling Host MicroRNA Responses to Henipavirus Infection
- Recently Emerged Novel Henipa-like Viruses: Shining a Spotlight on the Shrew
- Sequence basis for selectivity of ephrin-B2 ligand for Eph receptors and pathogenic henipavirus G glycoproteins
- Severe zoonotic viruses carried by different species of bats and their regional distribution
- Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination
- Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein
- Structural Studies of Henipavirus Glycoproteins
- Structure and antigenicity of divergent Henipavirus fusion glycoproteins
- Structure and design of Langya virus glycoprotein antigens
- Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopes
- Surveillance of Nipah virus in Pteropus medius of Kerala state, India, 2023
- Syrian Golden Hamster Model for Nipah Virus Infection
- Tackling a global epidemic threat: Nipah surveillance in Bangladesh, 2006-2021
- The cryo-EM structure of homotetrameric attachment glycoprotein from langya henipavirus
- The escalation of NiV infection: Epidemiological trends, clinical manifestations, and global implications
- The recent Nipah virus outbreak in Bangladesh could be a threat for global public health: A brief report
- Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates
- Updated Insights into the Phylogenetics, Phylodynamics, and Genetic Diversity of Nipah Virus (NiV)
- Utilizing Recombinant Reporter Henipaviruses to Conduct Antiviral Screening
- Vaccines based on the fusion protein consensus sequence protect Syrian hamsters from Nipah virus infection
- Viral-induced neuroinflammation: Different mechanisms converging to similar exacerbated glial responses
- Viruses present in the environment: virological considerations and examples of their impact on human health